Locations:
SearchAdvertisement
FDA-approved therapy offers promise for patients with castrate-resistant prostate cancer
Breaking through barriers in cancer care
The cornerstone of a successful doctor-patient relationship
Dr. Aaron Gerds argues for more balance in safety reporting
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Cancers that predominantly affect Black patients and cancers with higher mortality rates receive less funding
Study shows encouraging safety results in rare type of adult brain cancer
Novel assay identifies women most likely to benefit
Study presented at ASTRO 2021 shows promise in patients treated with stereotactic radiosurgery
Drug beats standard care for the treatment of relapsed or refractory ALL
Oncologist argues the "yes" culture of medicine leads to imbalance
Advertisement
Advertisement